{
    "headline": "Fda Approves Pfizer Booster Shots People Over 65 Or High Risk",
    "summary": "On Wednesday, the U.S. Food and Drug Administration (FDA) approved\u00a0a third shot\u00a0of the\u00a0Pfizer\u00a0and BioNTech coronavirus vaccine for individuals\u00a0ages\u00a065 and older, and those who are at high risk or have high-risk jobs (such as health care workers and teachers).\u00a0 The CDC estimates that about 53 million Americans are aged 65 and older, and another 20 million are health care workers,\u00a0and up to 100 million people have medical conditions that put them at increased risk.\u00a0 The FDA approval clears the way for fast distribution of the shots, which would be administered six\u00a0months after the second dose.Last week, an advisory panel to the FDArejected approval of the booster shot for other individuals, saying there was not enough evidence to support the authorization.",
    "story": {
        "left": [
            "https://www.usatoday.com/story/news/health/2021/09/22/covid-fda-booster-pfizer-vaccine-people-65-older-high-risk/5799348001/"
        ],
        "center": [
            "https://www.statnews.com/2021/09/22/fda-authorizes-pfizers-covid-19-booster-for-people-over-65-or-at-high-risk/"
        ],
        "right": [
            "https://www.foxbusiness.com/politics/fda-expected-to-authorize-pfizer-booster-shots-for-seniors-high-risk-people"
        ]
    }
}